- Home
- MHK vs DVA Comparison
MHK vs DVA Comparison
Compare MHK & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHK
- DVA
- Stock Information
- Founded
- MHK 1988
- DVA 1994
- Country
- MHK United States
- DVA United States
- Employees
- MHK N/A
- DVA N/A
- Industry
- MHK Home Furnishings
- DVA Misc Health and Biotechnology Services
- Sector
- MHK Consumer Discretionary
- DVA Health Care
- Exchange
- MHK Nasdaq
- DVA Nasdaq
- Market Cap
- MHK 8.2B
- DVA 9.4B
- IPO Year
- MHK 1992
- DVA 1995
- Fundamental
- Price
- MHK $121.96
- DVA $127.94
- Analyst Decision
- MHK Buy
- DVA Hold
- Analyst Count
- MHK 14
- DVA 3
- Target Price
- MHK $143.57
- DVA $154.67
- AVG Volume (30 Days)
- MHK 688.6K
- DVA 790.0K
- Earning Date
- MHK 10-23-2025
- DVA 10-28-2025
- Dividend Yield
- MHK N/A
- DVA N/A
- EPS Growth
- MHK N/A
- DVA 8.72
- EPS
- MHK 7.53
- DVA 10.20
- Revenue
- MHK $10,684,100,000.00
- DVA $13,161,328,000.00
- Revenue This Year
- MHK N/A
- DVA $5.96
- Revenue Next Year
- MHK $2.76
- DVA $3.54
- P/E Ratio
- MHK $16.23
- DVA $12.54
- Revenue Growth
- MHK N/A
- DVA 5.09
- 52 Week Low
- MHK $96.24
- DVA $126.07
- 52 Week High
- MHK $164.29
- DVA $179.60
- Technical
- Relative Strength Index (RSI)
- MHK 35.50
- DVA 45.56
- Support Level
- MHK $125.52
- DVA $127.88
- Resistance Level
- MHK $131.03
- DVA $131.84
- Average True Range (ATR)
- MHK 2.64
- DVA 2.47
- MACD
- MHK -1.07
- DVA 0.11
- Stochastic Oscillator
- MHK 2.48
- DVA 42.70
About MHK Mohawk Industries Inc.
Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Geographically, it derives a majority of its revenue from the United States, while it also operates in Latin America, Europe and Others.
About DVA DaVita Inc.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.